Polycystic Ovary Syndrome Linked to Higher Heart Disease Risk

A new analysis of clinical data from more than 400,000 U.S. women aged 18‑50 with polycystic ovary syndrome – now termed metabolic polyendocrine ovarian syndrome (SOMP) – found a significantly increased risk of cardiovascular disease. The study, published in The Lancet Obstetrics, Gynecology & Women's Health, showed that women with the condition were more likely to have risk factors such as diabetes, dyslipidaemia, obesity and hypertension, and also faced higher rates of atherosclerotic heart disease, heart attacks, angina and stroke. Notably, the elevated risk persisted even in women without traditional risk factors.

Researchers urge clinicians to improve cardiovascular screening for patients with SOMP and to educate health‑care professionals about these hidden effects. The findings highlight the broader metabolic and endocrine implications of a disorder that affects millions of women worldwide.